Development Research Plan
发展研究计划
基本信息
- 批准号:8234057
- 负责人:
- 金额:$ 62.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministratorBiologicalBioterrorismCategoriesCommunicationComplementDefectDevelopmentDiagnosticElectronicsEmerging Communicable DiseasesEmerging TechnologiesFundingGeneticGoalsGrowthImmune systemLeadMeasuresMissionNational Institute of Allergy and Infectious DiseaseNatural ImmunityOregonPacific NorthwestPilot ProjectsPoliciesResearchResearch PersonnelResearch Project GrantsRiskScientistSystemSystems BiologyTalentsTechnologyTranslational ResearchWashingtonadaptive immunityage relatedbasebiodefensecombatflexibilityinnovationnovelpathogenproduct developmentprogramsresearch and developmenttherapeutic vaccinevaccine development
项目摘要
The goal of the Developmental Research Plan is to identify and support pilot projects that complement the
strategic mission of the PNWRCE. The PNWRCE will advance strategies to combat NIAID Category A-C
agents via the development of two themes: "Identification of age-related defects in the immune system to
facilitate the development of vaccines and supplemental therapies" and "The use of systems biology and
systems genetics approaches to define pathogen-host interactions and mechanisms of innate and adaptive
immunity." Applications will be encouraged from scientists within the RCE and from eligible regional
scientists wishing to move into biodefense/EID research. Thus, we will leverage the pilot project mechanism
to expand the scope and excellence of biodefense/EID research in the PNW region and develop a cutting
edge research portfolio to sustain and enrich Center's activities. Three Specific Aims are proposed to
achieve these goals: (1) To solicit, identify and support developmental research projects ("pilot" projects) that
expand the scope and range of investigators within the Pacific Northwest (PNW) region and take advantage
of novel ideas and emerging technologies relevant to PNWRCE themes. (2) To support the growth of
successful pilot projects into independent research grants that will lead to development of products
(vaccines, therapeutics or diagnostics) against NIAID A-C pathogens or key advances in biodefense/EID
research. (3) To create, through the pilot project mechanism, a platform of emergent talents and
technologies that could enhance or replace existing research projects, thereby creating flexibility for the
Center to prioritize and advance in the most promising research directions. We will use electronic
communication systems in association with established translational research initiatives in Oregon (OCTRI)
and Washington (CTSA) to solicit applications from a broad talent base of eligible scientists. In accordance
with NIAID policies, we will select, fund and manage successful applications via an interactive committee of
Center scientists, administrators and external advisors. Our mission is to maintain the Center's excellence
through supporting projects with high potential for product development and maturation into independent
research programs.
发展研究计划的目的是识别和支持与之补充的试点项目
PNWRCE的战略任务。 PNWRCE将提出与NIAID类别a-c对抗的策略
通过开发两个主题的代理:“免疫系统中与年龄相关的缺陷的识别
促进疫苗和补充疗法的开发”和“系统生物学的使用和
系统遗传学方法来定义病原体宿主相互作用以及先天和适应性的机制
免疫力。
希望进入Biodefense/EID研究的科学家。因此,我们将利用试点项目机制
扩大PNW地区生物浮雕/开斋节研究的范围和卓越,并开发削减
边缘研究组合维持和丰富中心的活动。提出了三个具体目标
实现这些目标:(1)征求,识别和支持发展研究项目(“试点”项目)
扩大西北太平洋地区(PNW)地区的调查人员的范围和范围并利用优势
与PNWRCE主题相关的新颖思想和新兴技术。 (2)支持
成功的飞行员项目进入独立的研究补助金,这将导致产品开发
(疫苗,治疗剂或诊断)针对NIAID A-C病原体或Biodefense/EID的关键进展
研究。 (3)通过试点项目机制创建一个新兴才能的平台,
可以增强或取代现有研究项目的技术,从而为
沿最有希望的研究方向进行优先级和进步的中心。我们将使用电子
与俄勒冈州既定的转化研究计划(OCTRI)结合的通信系统
华盛顿(CTSA)征求合格科学家的广泛人才基础的申请。根据
通过NIAID政策,我们将通过一个交互式委员会选择,资助和管理成功的申请
中心科学家,管理员和外部顾问。我们的使命是保持中心的卓越性
通过支持具有很高潜力的产品开发和成熟到独立的项目
研究计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHLEE V. MOSES其他文献
ASHLEE V. MOSES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHLEE V. MOSES', 18)}}的其他基金
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.
KSHV 操纵宿主铁代谢和铁死亡细胞死亡途径,为治疗干预创造新的脆弱点。
- 批准号:
10155452 - 财政年份:2020
- 资助金额:
$ 62.39万 - 项目类别:
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.
KSHV 操纵宿主铁代谢和铁死亡细胞死亡途径,为治疗干预创造新的脆弱点。
- 批准号:
10079716 - 财政年份:2020
- 资助金额:
$ 62.39万 - 项目类别:
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.
KSHV 操纵宿主铁代谢和铁死亡细胞死亡途径,为治疗干预创造新的脆弱点。
- 批准号:
10400156 - 财政年份:2020
- 资助金额:
$ 62.39万 - 项目类别:
KSHV Manipulates Host Iron Metabolism and Ferroptotic Cell Death Pathways, Creating Novel Vulnerability Points for Therapeutic Intervention.
KSHV 操纵宿主铁代谢和铁死亡细胞死亡途径,为治疗干预创造新的脆弱点。
- 批准号:
10617677 - 财政年份:2020
- 资助金额:
$ 62.39万 - 项目类别:
Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
血红素加氧酶-1 作为肿瘤因子和卡波西肉瘤的治疗靶点
- 批准号:
9248335 - 财政年份:2015
- 资助金额:
$ 62.39万 - 项目类别:
MECHANISMS OF KSHV-INDUCED CELLULAR TRANSFORMATION
KSHV 诱导的细胞转化机制
- 批准号:
8173190 - 财政年份:2010
- 资助金额:
$ 62.39万 - 项目类别:
Characterization of Vpu-mediated degradation of BST-2
Vpu 介导的 BST-2 降解的表征
- 批准号:
8646860 - 财政年份:2010
- 资助金额:
$ 62.39万 - 项目类别:
Characterization of Vpu-mediated degradation of BST-2
Vpu 介导的 BST-2 降解的表征
- 批准号:
8458052 - 财政年份:2010
- 资助金额:
$ 62.39万 - 项目类别:
Characterization of Vpu-mediated degradation of BST-2
Vpu 介导的 BST-2 降解的表征
- 批准号:
8065911 - 财政年份:2010
- 资助金额:
$ 62.39万 - 项目类别:
THE ROLE OF HIV-1 VPU IN THE REGULATION OF CD40
HIV-1 VPU 在 CD40 调节中的作用
- 批准号:
8173207 - 财政年份:2010
- 资助金额:
$ 62.39万 - 项目类别:
相似海外基金
CBESS: a pipeline program to increase linguistic and geographic diversity in STEM + health
CBESS:一项旨在增加 STEM 健康领域语言和地理多样性的管道计划
- 批准号:
10665432 - 财政年份:2023
- 资助金额:
$ 62.39万 - 项目类别:
Addressing Dental and Psychiatric Comorbidities: Screening and Referrals of HIV/AIDS Patients
解决牙科和精神合并症:艾滋病毒/艾滋病患者的筛查和转诊
- 批准号:
10671164 - 财政年份:2023
- 资助金额:
$ 62.39万 - 项目类别:
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
SPORE 德克萨斯大学 MD 安德森癌症中心 - 白血病
- 批准号:
10911713 - 财政年份:2023
- 资助金额:
$ 62.39万 - 项目类别: